Industry-academia collaborations, seminar series by Cancer Research KI
Cancer Research KI launches a new seminar series on Industrial Collaboration. We will discuss topics such as legal issues, commission, collaboration but also there will be a chance to get inspired by researchers, who have already collaborated with the industry.
Programme for the seminar on the 5th of December, 2022
Topic: “Clinical Cancer Trials with an Emphasis on Early Experimental Studies and Collaboration with the Pharmaceutical Industry and Biotech companies
Speaker: Jeffrey Yachnin, Senior Consultant Karolinska Comprehensive Cancer Center Department of Clinical Cancer Studies, Cancer Theme, Karolinska University Hospital
Venue: Inghesalen Tomtebodavägen 18a, 171 65 Solna Campus or Zoom ( a link will be sent after registration)
Welcome to the hybrid seminar organised by Cancer Research KI. There will be time to discuss and ask questions during the afternoon. Please join either via zoom or in real life where fika will be served before the meeting. Details obtained after the registration.
Programme for the seminar on the 12th of October, 2022
Venue: Scheelesalen Tomtebodavägen 6, 171 65 Solna Campus or Zoom ( a link will be sent after registration)
Welcome to the hybrid seminar organised by Cancer Research KI. Swedish Intellectual Property Office (PRV) will give a talk about about how to create value around Intellectual Property (IP) as a researcher. Hans-Gustaf Ljunggren will present a couple of examples of IP.
13.00 - 13.45 "How to create value around IP as a researcher" Carl Hamsten
13.45 - 14.00 Examples by a researcher, Hans-Gustaf Ljunggren
14.00 -14.15 KI perspective, Richard Cowburn (how to deal with confidentiality, teachers perspective)
14.15 - 15.00 Panel discussion and answers to questions
Programme for the seminar on the 19th of May, 2022, KI/Merck: existing and potential collaborations
During this seminar, you will learn how Merck is looking to expand their ongoing collaboration with KI in the areas of oncology and immuno-oncology. An ongoing project will also be presented. There will be time to discuss and ask questions during the afternoon.
13.45-14.00 : Coffee and networking
14.00-14.10 : Welcome and Introduction Simon Ekman (Cancer Research KI) and Sven Pötzsch (Merck Healthcare KGaA)
14.10- 14.30 : Richard Cowburn (KI) KI perspectives on Industry/Academia Partnerships the research area of Oncology
14.30- 14.50 : Kahina Lang (Merck Healthcare KGaA) Strategic Innovation at Merck: Motivation and Mission
14.50- 14.55: Short break
14.55- 15.15 : Eike-Benjamin Braune (KI) Modulation of NOTCH Signaling as a new treatment option for solid tumors
15.15- 15.35 : Felix Geist (Merck Healthcare KGaA) Identification of a NOTCH transcriptomic signature for basal like breast cancer
15.35-15.55: Simon Ekman (Cancer Research KI), Richard Cowburn (KI) and Sven Pötzsch (Merck Healthcare KGaA) Open discussion
15.55: Closing remarks Simon Ekman
Programme for the seminar on January 20th, 2022
13.00 Welcoming words: Simon Ekman Leader of the Industrial collaboration working group CRKI
13.10 Why collaborate with industry? High-level examples of industrial relations KI have established within oncology: Richard Cowburn
14.00 Short break
14.10 KI processes and ways of working with industry: Richard Cowburn and External Engagement office
15.00 Conclusions and final remarks
Please register by sending an e-mail to cancerresearchKI@ki.se by Monday 17th of January